z-logo
open-access-imgOpen Access
Traditional and complementary medicine use in patients with type 2 diabetes: Findings from a multicenter cross-sectional questionnaire survey in Selangor, Malaysia
Author(s) -
Yieng Yii Wong,
Azizul Hakim Sulaiman,
Anis Aeida Mat Jaya,
Pei Zan Wan,
Anchaya Eh Wan,
Nurieshah Hanim Mohd Anuar,
Rajkumar Selvaraju,
Kok Pim Kua
Publication year - 2021
Publication title -
progress in drug discovery and biomedical science
Language(s) - English
Resource type - Journals
ISSN - 2710-6039
DOI - 10.36877/pddbs.a0000224
Subject(s) - medicine , cross sectional study , diabetes mellitus , type 2 diabetes , population , family history , traditional medicine , ethnic group , adverse effect , prevalence , family medicine , type 2 diabetes mellitus , environmental health , endocrinology , pathology , sociology , anthropology
Current global estimates of traditional and complementary medicine (T&CM) utilization range from 9.8% to 76%, with high rates of use being documented in Japan, South Korea, and Malaysia. Previous research has shown that patients with diabetes are more likely to use T&CM than individuals without diabetes. A multicenter cross-sectional survey of patients with type 2 diabetes mellitus was conducted at five primary care health clinics in Petaling district of Selangor, Malaysia from June 1, 2020 through September 30, 2020. A total of 476 patients were enrolled. 58.0% of men and 64.8% of women reported to use at least a type of T&CM. The prevalence of T&CM use among Malays, Chinese, and Indians was 71.1%, 33.3%, and 62.9% respectively. The most commonly used T&CM were herbal remedies (45.2%), followed by nutritional supplements (9.9%). 80.0% of the patients would follow their doctor’s instruction if the doctor asked them not to use T&CM, whereas 70.2% would consult their doctor about using T&CM. Factors associated with higher tendency for T&CM use comprised increased age, unemployed, oral antidiabetic monotherapy, presence of family history of diabetes, and coexisting chronic disease. T&CM therapies were common among multi-ethnic patient population with type 2 diabetes. The high rate of use warranted clinical attention and intervention to reduce the risk of drug-associated adverse events.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom